 Flow cytometric determination multidrug resistant phenotype transitional cell cancer bladder implications applications experience monoclonal antibody cell surface P-glycoprotein product multidrug resistance gene human bladder total patients different specimens samples normal bladders transitional cell carcinomas mucinous adenocarcinoma bladder wall specimens nonmalignant urothelial samples cystectomies P-glycoprotein normal adult pediatric bladder Bladder children neurogenic bladder enhanced expression positivity Transitional cell carcinoma low expression diagnosis patients initial expression patients chemotherapy expression Nonmalignant tissue cystectomy specimens low expression specificity system human bladder cell lines ability flow cytometry expression early detection chemotherapy resistance patients transitional cell carcinoma systemic intravesical therapy